Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development
Authors
Keywords
Inflammation, Inflammatory diseases, Cytokines, Hematopoietic stem cells, Mathematical modeling, Stem cells, Inflammatory bowel disease, Macrophages
Journal
PLoS One
Volume 12, Issue 8, Pages e0183620
Publisher
Public Library of Science (PLoS)
Online
2017-09-01
DOI
10.1371/journal.pone.0183620
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Age-Related Macular Degeneration in Patients With Chronic Myeloproliferative Neoplasms
- (2017) Marie Bak et al. JAMA Ophthalmology
- Emergence of heterogeneity in acute leukemias
- (2016) Thomas Stiehl et al. Biology Direct
- Metastasis: new functional implications of platelets and megakaryocytes
- (2016) Raphael Leblanc et al. BLOOD
- Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms
- (2016) Anders Lindholm Sørensen et al. LEUKEMIA RESEARCH
- A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis
- (2016) Vibe Skov et al. PLoS One
- Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells
- (2015) M. Lu et al. BLOOD
- Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis
- (2015) Fiorella Ciaffoni et al. BLOOD CELLS MOLECULES AND DISEASES
- Cell Division Patterns in Acute Myeloid Leukemia Stem-like Cells Determine Clinical Course: A Model to Predict Patient Survival
- (2015) T. Stiehl et al. CANCER RESEARCH
- Smoking and philadelphia-negative chronic myeloproliferative neoplasms
- (2015) Anders Lindholm Sørensen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera
- (2015) Caroline H. Riley et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms
- (2015) Anneli Enblom et al. European Journal of Internal Medicine
- Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone
- (2015) J-J Kiladjian et al. LEUKEMIA
- The Hen or the Egg: Inflammatory Aspects of Murine MPN Models
- (2015) Jonas S. Jutzi et al. MEDIATORS OF INFLAMMATION
- Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
- (2015) Qian Zhang et al. NATURE
- Fibrosis — A Common Pathway to Organ Injury and Failure
- (2015) Don C. Rockey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms
- (2015) William Tapper et al. Nature Communications
- JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
- (2015) M. Kleppe et al. Cancer Discovery
- Inflammation-Induced Cell Proliferation Potentiates DNA Damage-Induced Mutations In Vivo
- (2015) Orsolya Kiraly et al. PLoS Genetics
- Tumors: Wounds That Do Not Heal--Redux
- (2015) H. F. Dvorak Cancer Immunology Research
- Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study
- (2015) Henrik Frederiksen et al. Lancet Haematology
- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- (2014) P. Lundberg et al. BLOOD
- From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms
- (2014) M. Cazzola et al. BLOOD
- The Resolution of Inflammation: A Mathematical Model of Neutrophil and Macrophage Interactions
- (2014) J. L. Dunster et al. BULLETIN OF MATHEMATICAL BIOLOGY
- Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state
- (2014) Mads Emil Bjørn et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis
- (2014) Helna Pettersson et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Expansion of circulating CD56brightnatural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
- (2014) Caroline H. Riley et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications
- (2014) Emmanuel Pourcelot et al. EXPERIMENTAL HEMATOLOGY
- JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate
- (2014) C. Nielsen et al. HAEMATOLOGICA
- Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms
- (2014) Alexander Sidelmann Christensen et al. LEUKEMIA RESEARCH
- Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat
- (2014) Christen Lykkegaard Andersen et al. LEUKEMIA RESEARCH
- The platelet–cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?
- (2014) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Whole Blood Transcriptional Profiling Reveals Deregulation of Oxidative and Antioxidative Defence Genes in Myelofibrosis and Related Neoplasms. Potential Implications of Downregulation of Nrf2 for Genomic Instability and Disease Progression
- (2014) Hans Carl Hasselbalch et al. PLoS One
- Perspectives on the impact of JAK-inhibitor therapy upon inflammation-mediated comorbidities in myelofibrosis and related neoplasms
- (2014) Hans C Hasselbalch Expert Review of Hematology
- An Immune Dysregulation in MPN
- (2014) Giovanni Barosi Current Hematologic Malignancy Reports
- Feedback Signals in Myelodysplastic Syndromes: Increased Self-Renewal of the Malignant Clone Suppresses Normal Hematopoiesis
- (2014) Thomas Walenda et al. PLoS Computational Biology
- Community-acquired infections and their association with myeloid malignancies
- (2013) Glen J. Titmarsh et al. Cancer Epidemiology
- The role of cytokines in the initiation and progression of myelofibrosis
- (2013) Hans C. Hasselbalch CYTOKINE & GROWTH FACTOR REVIEWS
- Transcription factor nuclear factor erythroid-2 mediates expression of the cytokine interleukin 8, a known predictor of inferior outcome in patients with myeloproliferative neoplasms
- (2013) J. Wehrle et al. HAEMATOLOGICA
- MPN patients harbor recurrent truncating mutations in transcription factor NF-E2
- (2013) Jonas S. Jutzi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis
- (2013) T Barbui et al. LEUKEMIA
- Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis
- (2013) Vibe Skov et al. LEUKEMIA & LYMPHOMA
- A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis?
- (2013) Hans C. Hasselbalch LEUKEMIA RESEARCH
- Bifurcation analysis of an existing mathematical model reveals novel treatment strategies and suggests potential cure for type 1 diabetes
- (2013) K. H. M. Nielsen et al. MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bone Marrow Injury Induced via Oxidative Stress in Mice by Inhalation Exposure to Formaldehyde
- (2013) Yuchao Zhang et al. PLoS One
- A Mathematical Model of Cancer Stem Cell Driven Tumor Initiation: Implications of Niche Size and Loss of Homeostatic Regulatory Mechanisms
- (2013) Sara N. Gentry et al. PLoS One
- Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
- (2013) Richard T Silver et al. Expert Review of Hematology
- Inflammation and Immune System Activation in Aging: A Mathematical Approach
- (2013) Jason B. Nikas Scientific Reports
- Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis
- (2012) Rakhee Vaidya et al. AMERICAN JOURNAL OF HEMATOLOGY
- Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
- (2012) H. C. Hasselbalch BLOOD
- Demand-adapted regulation of early hematopoiesis in infection and inflammation
- (2012) H. Takizawa et al. BLOOD
- Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis
- (2012) Vibe Skov et al. EXPERIMENTAL HEMATOLOGY
- A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2
- (2012) Kai B. Kaufmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mathematical model of colitis-associated colon cancer
- (2012) Wing-Cheong Lo et al. JOURNAL OF THEORETICAL BIOLOGY
- Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance
- (2012) Vibe Skov et al. LEUKEMIA RESEARCH
- Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
- (2012) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Mathematical modelling of cytokine-mediated inflammation in rheumatoid arthritis
- (2012) M. Baker et al. MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA
- Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
- (2012) Giovanni Barosi et al. PLoS One
- Mathematical Modeling of Leukemogenesis and Cancer Stem Cell Dynamics
- (2012) T. Stiehl et al. Mathematical Modelling of Natural Phenomena
- TNF facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
- (2011) A. G. Fleischman et al. BLOOD
- Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study
- (2011) H. Frederiksen et al. BLOOD
- Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-
- (2011) C. H. Riley et al. BLOOD
- Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
- (2011) Vibe Skov et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Monocytes link atherosclerosis and cancer
- (2011) Mikael J. Pittet et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?
- (2011) S. Hermouet et al. HAEMATOLOGICA
- Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
- (2011) Magnus Björkholm et al. JOURNAL OF CLINICAL ONCOLOGY
- A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
- (2011) Hans Carl Hasselbalch Expert Review of Hematology
- Molecular pathways and targets in cancer-related inflammation
- (2010) Alberto Mantovani et al. ANNALS OF MEDICINE
- Inflammation in Peripheral Artery Disease
- (2010) Gregorio Brevetti et al. CIRCULATION
- Of mice and men: Human RNA polymerase III promoter U6 is more efficient than its murine homologue for shRNA expression from a lentiviral vector in both human and murine progenitor cells
- (2010) Roland Roelz et al. EXPERIMENTAL HEMATOLOGY
- The JAK2 V617F somatic mutation, mortality and cancer risk in the general population
- (2010) C. Nielsen et al. HAEMATOLOGICA
- Autoimmunity and the risk of myeloproliferative neoplasms
- (2010) S. Y. Kristinsson et al. HAEMATOLOGICA
- Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
- (2010) T. Barbui et al. HAEMATOLOGICA
- Monocytes and Macrophages Regulate Immunity through Dynamic Networks of Survival and Cell Death
- (2010) Arti Parihar et al. Journal of Innate Immunity
- Characterization of stem cells using mathematical models of multistage cell lineages
- (2010) Thomas Stiehl et al. MATHEMATICAL AND COMPUTER MODELLING
- Genetic factors in chronic inflammation: Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population
- (2010) Lynnette R. Ferguson et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Chronic inflammation and mutagenesis
- (2010) Lynnette R. Ferguson MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- A mathematical framework to determine the temporal sequence of somatic genetic events in cancer
- (2010) Camille Stephan-Otto Attolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- General Model of Inflammation
- (2009) Meagan C. Herald BULLETIN OF MATHEMATICAL BIOLOGY
- A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
- (2009) Damla Olcaydu et al. NATURE GENETICS
- A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
- (2009) Outi Kilpivaara et al. NATURE GENETICS
- JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
- (2009) Amy V Jones et al. NATURE GENETICS
- A progenitor cell origin of myeloid malignancies
- (2009) H. Haeno et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mathematical Models of Cancer Stem Cells
- (2008) Franziska Michor JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
- (2008) Jeffrey C Barrett et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation